-+ 0.00%
-+ 0.00%
-+ 0.00%

Spero Therapeutics Appoints William Ho to Board and Development Committee

PUBT·11/12/2026 21:08:12
Listen to the news
Spero Therapeutics Appoints William Ho to Board and Development Committee
  • Spero Therapeutics appointed William Ho to its board and Development Committee effective November 10, 2026; he brings over 20 years’ clinical development experience.
  • Patrick Vink stepped down from the board concurrently, ending 11 years of service.
  • Debra Jeske Zack became chief medical officer in July 2026; she previously held that role at Exagen.
  • Amy Rock was recently appointed chief regulatory and quality officer to lead global regulatory strategy, quality and pharmacovigilance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spero Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611121605PRIMZONEFULLFEED9876515) on November 12, 2026, and is solely responsible for the information contained therein.